Bittorf Birgit, Merkel Susanne, Matzel Klaus E, Wein Axel, Dimmler Arno, Hohenberger Werner
Department of Surgery, University of Erlangen-Nuremburg, Krankenhausstrasse 12, 91054 Erlangen, Germany.
Langenbecks Arch Surg. 2004 Jun;389(3):178-83. doi: 10.1007/s00423-004-0474-y. Epub 2004 May 14.
Objective of the study was to investigate particular clinicopathological features of colorectal signet-ring cell carcinoma.
The data of 34 patients with primary colorectal signet-ring cell carcinoma were compared with those of 4,458 consecutive patients with primary non-signet-ring cell colorectal adenocarcinoma between 1978 and 1999. For outcome analysis patients, after curative resection of signet-ring cell cancer, were matched for age, gender, tumour site and stage with patients suffering from poorly differentiated non-signet-ring cell colorectal adenocarcinoma.
Signet-ring cell carcinoma patients were significantly younger than patients with non-signet-ring cell colorectal adenocarcinoma (median age 60 years vs 64 years, P=0.033). The most common tumour sites were the rectum (47%) and the right hemicolon (29%). They presented with significantly more advanced tumour stages and a significantly higher frequency of distant metastases (44% vs 21%, P=0.002). The rate of curative resections was significantly lower (35% vs 79%, P<0.001). However, the prognosis after curative resection of signet-ring cell cancer was as poor as in poorly differentiated non-signet-ring cell colorectal adenocarcinoma of the same stage (5-year survival rate 46% vs 57%, p=0.935).
Colorectal signet-ring cell carcinoma is characterized by diagnosis in more advanced tumour stages resulting in lower rates of curative resection. Prognosis is as poor as in non-signet-ring cell colorectal cancer of low differentiation in the same stage.
本研究的目的是调查结直肠印戒细胞癌的特定临床病理特征。
将34例原发性结直肠印戒细胞癌患者的数据与1978年至1999年间连续收治的4458例原发性非印戒细胞结直肠腺癌患者的数据进行比较。为了进行预后分析,对印戒细胞癌根治性切除术后的患者,按照年龄、性别、肿瘤部位和分期与低分化非印戒细胞结直肠腺癌患者进行匹配。
印戒细胞癌患者明显比非印戒细胞结直肠腺癌患者年轻(中位年龄60岁对64岁,P = 0.033)。最常见的肿瘤部位是直肠(47%)和右半结肠(29%)。他们的肿瘤分期明显更晚,远处转移的频率明显更高(44%对21%,P = 0.002)。根治性切除率明显更低(35%对79%,P < 0.001)。然而,印戒细胞癌根治性切除术后的预后与同阶段低分化非印戒细胞结直肠腺癌一样差(5年生存率46%对57%,p = 0.935)。
结直肠印戒细胞癌的特点是在肿瘤更晚期被诊断出来,导致根治性切除率较低。预后与同阶段低分化非印戒细胞结直肠癌一样差。